| scientific journal | Q5633421 |
| P8375 | Crossref journal ID | 120805 |
| P236 | ISSN | 2041-6792 |
| 2041-6806 | ||
| P7363 | ISSN-L | 2041-6792 |
| P1277 | JUFO ID | 70235 |
| P1055 | NLM Unique ID | 101554582 |
| P856 | official website | http://www.future-science.com/loi/cli |
| P10283 | OpenAlex ID | S2765044866 |
| P3181 | OpenCitations bibliographic resource ID | 1551827 |
| P7662 | Scilit journal ID | 532891 |
| P495 | country of origin | United Kingdom | Q145 |
| P407 | language of work or name | English | Q1860 |
| P1476 | title | Clinical investigation |
| Q128930427 | A comparison of liprotamase, a non-porcine pancreatic enzyme replacement therapy, to porcine extracted pancrelipase in a noninferiority randomized clinical trial in patients with cystic fibrosis |
| Q34820877 | An evaluation of recruitment methods utilized for a clinical trial with periodontal and diabetes enrollment criteria: the Diabetes and Periodontal Therapy Trial |
| Q36298863 | Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer |
| Q115334126 | Antibiotic treatment of acute otitis media in children: to wait or not to wait? |
| Q56880368 | CONSORT 2010: progress and challenges |
| Q30514152 | Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings |
| Q58811348 | Clinical trials in pediatrics |
| Q128931992 | Comparison of neuromuscular fatigue in chronic stroke patients with healthy controls |
| Q129520559 | Comparison of the effect of intravenous saline hydration on serum creatinine concentration between patients with or without iodine contrast administration |
| Q37327945 | Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia |
| Q35570541 | Cyclosporine ophthalmic emulsions for the treatment of dry eye: a review of the clinical evidence |
| Q30902176 | Data fraud in clinical trials |
| Q35789708 | Design of clinical trials for biomarker research in oncology |
| Q35215307 | Design of clinical trials of antibacterial agents for community-acquired bacterial pneumonia |
| Q28714253 | Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network |
| Q34149294 | Efficacy and safety of a unique enteric-coated bicarbonate-buffered pancreatic enzyme replacement therapy in children and adults with cystic fibrosis |
| Q130205370 | Evaluation of Edible Oyster Mushroom (Pleurotus ostreatus) on Oxidative Stress and Neurological Cognitive Disorder in Streptozotocin –Diabetic Rats |
| Q35762863 | Experience in international clinical research: the HIV Prevention Trials Network |
| Q39347818 | Genetic biomarkers of placebo response: what could it mean for future trial design? |
| Q37438644 | HIV PrEP Trials: The Road to Success |
| Q36464748 | HIV Vaccine Trials Network: activities and achievements of the first decade and beyond |
| Q34702964 | How can we manage resistance to antiangiogenic drugs? |
| Q61856860 | Identifying and prioritizing unmet research questions for people with tinnitus: the James Lind Alliance Tinnitus Priority Setting Partnership |
| Q117322238 | Improving the treatment outcome in follicular lymphoma using rituximab maintenance |
| Q35827318 | Incentives and barriers to neurological clinical research participation |
| Q110986823 | Incidental findings in clinical research: the case of the ‘known unknowns’ |
| Q57358108 | Information wants to be free, but when it comes to clinical trials can we afford to let it be? |
| Q60613424 | Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment of metastatic breast cancer |
| Q33705743 | Measuring symptoms as a critical component of drug development and evaluation in hematological diseases |
| Q35799389 | Neoplastic meningitis resulting from hematological malignancies: pharmacokinetic considerations and maximizing outcome |
| Q58118147 | New and emerging therapies for gout |
| Q58895808 | New approaches to the design of clinical trials in idiopathic pulmonary fibrosis |
| Q35910744 | New considerations in the design of clinical trials for amyotrophic lateral sclerosis |
| Q36641721 | New considerations in the design of clinical trials for the treatment of acute leukemia |
| Q35889519 | New considerations in the design of clinical trials for traumatic brain injury |
| Q37593414 | Noninferiority trials: clinical understandings and misunderstandings |
| Q35429544 | Novel agents in Waldenström macroglobulinemia. |
| Q40766794 | Novel oral taxane therapies: recent Phase I results |
| Q41949151 | Novel treatment options for ulcerative colitis |
| Q35801062 | Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease. |
| Q41837997 | Outcome measures in amyotrophic lateral sclerosis clinical trials |
| Q35541660 | Person-centric clinical trials: defining the N-of-1 clinical trial utilizing a practice-based translational network |
| Q36062762 | Personalized therapy for urothelial cancer: review of the clinical evidence |
| Q129520150 | Ph and residual gastric volume after mannitol preparation: A randomized controlled study comparing ingestion three versus six hours prior to the procedure |
| Q60492079 | Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges |
| Q129518183 | Possible impact of variations in some Cytokine levels during menstrual cycle in women of reproductive age infected with Pulmonary Tuberculosis at Nnewi, Nigeria' |
| Q128928449 | Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction |
| Q130204976 | Prescription Pattern Analysis of Antidiabetic Drugs in Diabetes Mellitus and Associated Comorbidities |
| Q128932638 | Proximate composition, mineral and some vitamin contents of tigernut (Cyperus esculentus) |
| Q110743086 | Research integrity in the modern era: current gaps in our knowledge and thinking |
| Q34377514 | Rethinking Phase II Clinical Trial Design in Heart Failure |
| Q34182834 | Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data |
| Q34040502 | Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis |
| Q114976332 | The challenges of dengue drug discovery and development |
| Q128928841 | The effect of nurses' communication skills with Nulliparous mothers on exclusive breastfeeding: A Clinical Trial Study |
| Q56485426 | The handling of missing data in clinical trials |
| Q38056914 | The unfolding treatment landscape for men with castration-resistant prostate cancer |
| Q34710368 | Treatment of Clostridium difficile infection: recent trial results |
| Q42184376 | Trials and tribulations of conducting medication trials: pediatric bipolar disorder as prototype |
| Q61647622 | Use of pharmacogenomics in psoriasis |
| Q114881577 | Using simulation to optimize adaptive trial designs: applications in learning and confirmatory phase trials |
| Q38406889 | Velaglucerase alfa in the treatment of Gaucher disease type 1 |
| Q42563520 | miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma |
| Q73496202 | Digoxinlike Immunoreactive Factor Isolated From Human Pleural Fluids is Structurally Similar to Digoxin | cites work | P2860 |
Search more.